SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

Share Price is delayed by 15 minutes
Get Live Data
992.00    44.00 (4.64%)
Bid:
972.00
Ask:
988.00
Spread: 16.00 (1.646%)
Market Cap: £271.52m
GHH Live PriceLast checked at - London Stock Exchange

Intraday Gooch & Housego Share Chart

AGM Statement

13 Feb 2008 11:00

Gooch & Housego PLC13 February 2008 For Immediate Release 13 February 2008 Gooch & Housego PLC (The "Company") Progress Update for Today's Annual General Meeting Gooch and Housego PLC, the specialist manufacturer of optical components andsystems, today announces a progress up-date. After a slower start to the year, demand is strengthening and order intakeduring the first few weeks of 2008 has been encouraging. Several of our keyQ-switch customers have placed long term (12 to 24 month) orders and we havealso secured a number of important design wins, most notably for fibre opticcomponents and modules from markets as diverse as biomedical,telecommunications, aerospace and defence. As a result, our order backlog is 14%higher today than it was at this time last year, and more than 15% higher thanat 1st October 2007. While the outlook remains favourable, sales of our acousto-optic products duringthe first quarter were lower than for the same period last year. The indicationsare that this was a temporary slowing of demand brought about by higher thannormal inventory levels at some of our customers, the cyclical nature of certainkey markets (semiconductors and microelectronics) and the uncertain economicclimate. We are now working to make up the ground lost in the first quarter andwe are expecting improved revenues in the second half of the year. Last month we launched our new, integrated components and materials businesscombining the activities of Gooch & Housego UK, Cleveland Crystals, NEOSTechnologies, Landwehr Electronics and SIFAM Fibre Optics. As a $60 millionannual revenue global optoelectronics business, we have enhanced our marketpresence, extended our global reach and reinforced our position as a leader inour field. The integration was well received by customers, who are supported bya new 18 strong sales and product management team, including newly opened salesoffices on the West Coast of the USA and in Hong Kong. As a fully integrated business we have also been able to embark on important newproduct development programmes that draw upon skills from several of ouroperating locations. The first products will be available towards the end ofthis calendar year and are expected to make an immediate contribution torevenues. In addition to organic growth via new product introductions, we arecontinuing to take a proactive approach to acquisitions in order to facilitateaccess to new markets. To support our growth plans we are creating additional manufacturing capacity.We recently began the relocation to our new factory in Ilminster which will morethan double usable manufacturing space. In Torquay we have embarked on a factoryextension that will provide 35% more space. In summary, despite a slower start to the year, we remain optimistic about thelong term prospects for Gooch & Housego based on the feedback we are receivingfrom our customers and supported by changes we have introduced in recent monthsto strengthen the business and our market position. Contacts: Gareth Jones, Chief Executive Officer, 01460 52271 Tim Thompson, Buchanan Communication Ltd, 020 7466 5000 Andrew Edwards, Oriel Securities Limited, 020 7710 7600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
23rd Jul 20127:00 amRNSProgress Update
12th Jun 20127:00 amRNSInterim Results
22nd May 20127:00 amRNSNotification of Interim Results
5th Apr 20127:00 amRNSHalf-Year Trading Update
14th Mar 20128:59 amRNSAIM Rule 20 - Annual Report
23rd Feb 201212:45 pmRNSAppointment of non-executive director
23rd Feb 20127:00 amRNSResults of Annual General Meeting
21st Feb 20127:00 amRNSTrading Update
29th Nov 20117:00 amRNSPreliminary Results
4th Nov 20114:35 pmRNSPrice Monitoring Extension
4th Oct 20117:00 amRNSFull-Year Trading Update
29th Sep 201111:52 amRNSBoard Change
8th Jun 20117:00 amRNSInterim Results
12th May 201112:24 pmRNSNotice of Results
1st Apr 20117:00 amRNSAcquisition and Trading Update
23rd Feb 20117:00 amRNSProgress Update for Today's Annual General Meeting
28th Jan 20118:10 amRNSDirector/PDMR Shareholding
25th Jan 20118:30 amRNSAcquisition of EM4
24th Jan 201112:07 pmRNSAdditional Listing
19th Jan 201111:45 amRNSUS Regulatory Approval
13th Jan 20114:55 pmRNSNotification of Interests
13th Jan 20114:55 pmRNSDirector Shareholdings
13th Jan 20114:53 pmRNSAdditional Listing
5th Jan 20111:42 pmRNSResult of EGM
16th Dec 20102:37 pmRNSProposed Acquisition, Placing and General Meeting
2nd Dec 20108:52 amRNSDividend
30th Nov 20107:00 amRNSPreliminary Results
15th Nov 20107:00 amRNSNotice of Results
5th Oct 20107:00 amRNSFull-Year Trading Update
17th Sep 20102:26 pmRNSHolding(s) in Company
13th Jul 20107:00 amRNSTrading Update
8th Jun 20107:00 amRNSInterim Results
18th May 20107:00 amRNSNotice of Results
8th Apr 20107:00 amRNSHalf-Year Trading Update
26th Mar 20103:33 pmRNSHolding(s) in Company
12th Mar 20108:56 amRNSDirector/PDMR Shareholding
25th Feb 201011:00 amRNSResult of AGM
24th Feb 20107:00 amRNSProgress Update for Today's Annual General Meeting
26th Jan 20108:24 amRNSDirector/PDMR Shareholding
18th Jan 20103:48 pmRNSAward of Share Options
7th Jan 20103:09 pmRNSAward of share-based incentives
1st Dec 20097:00 amRNSPreliminary Results
12th Nov 20098:56 amRNSNotice of Results
6th Oct 20097:00 amRNSFull-Year Trading Update
23rd Jul 20097:00 amRNSAppointment of new executive director
9th Jun 20097:00 amRNSInterim Results
13th May 20098:57 amRNSNotice of Results
2nd Apr 20097:00 amRNSResult of AGM
31st Mar 20097:00 amRNSHalf-Year Trading Update
23rd Mar 20097:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.